Biostar Pharmaceuticals, Inc. Derivative Liability
Biostar Pharmaceuticals, Inc. had Derivative Liability of $166.15 thousand as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2017-11-20
- 2017-09-30: Derivative Liability $166.15K.
- 2017-06-30: Derivative Liability $179.07K.
- 2017-03-31: Derivative Liability $438.51K.
- 2016-12-31: Derivative Liability $455.48K; Derivative Liability as first filed $59.20K.
| Period end | Derivative Liability | Derivative Liability as first filed |
|---|---|---|
| 2017-09-30 | $166.15K 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $179.07K 10-Q · filed 2017-11-15 | |
| 2017-03-31 | $438.51K 10-Q · filed 2017-05-19 | |
| 2016-12-31 | $455.48K 10-Q · filed 2017-11-20 | $59.20K 10-K · filed 2017-04-13 |
| 2016-09-30 | $12.70K 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $14.85K 10-Q · filed 2016-08-22 | |
| 2016-03-31 | $31.01K 10-Q · filed 2016-05-23 | |
| 2015-12-31 | $455.48K 10-K · filed 2017-04-13 | $59.20K 10-K · filed 2016-04-14 |
| 2014-12-31 | $383.30K 10-K · filed 2016-04-14 |